DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,199,497 | +3.3% | 12,896 | -0.1% | 0.22% | +7.5% |
| Q2 2023 | $3,096,720 | -1.4% | 12,903 | +3.5% | 0.20% | -6.9% |
| Q1 2023 | $3,142,182 | -7.7% | 12,467 | -2.8% | 0.22% | -16.0% |
| Q4 2022 | $3,405,338 | +2.3% | 12,830 | -0.5% | 0.26% | -6.5% |
| Q3 2022 | $3,330,000 | +1.2% | 12,896 | -0.6% | 0.28% | -17.2% |
| Q2 2022 | $3,289,000 | -16.4% | 12,977 | -3.3% | 0.33% | -2.1% |
| Q1 2022 | $3,934,000 | -10.7% | 13,414 | +0.2% | 0.34% | -6.9% |
| Q4 2021 | $4,403,000 | +7.9% | 13,384 | -0.1% | 0.36% | +8.0% |
| Q3 2021 | $4,080,000 | +12.0% | 13,404 | -1.3% | 0.34% | -7.9% |
| Q2 2021 | $3,644,000 | +15.4% | 13,581 | -3.2% | 0.37% | +8.3% |
| Q1 2021 | $3,158,000 | -0.6% | 14,035 | -1.9% | 0.34% | -13.8% |
| Q4 2020 | $3,178,000 | -4.1% | 14,309 | -7.0% | 0.39% | -16.9% |
| Q3 2020 | $3,313,000 | +35.8% | 15,386 | +11.5% | 0.47% | +23.6% |
| Q2 2020 | $2,440,000 | +26.9% | 13,801 | -0.7% | 0.38% | +0.8% |
| Q1 2020 | $1,923,000 | -10.0% | 13,898 | -0.2% | 0.38% | +10.8% |
| Q4 2019 | $2,136,000 | +8.5% | 13,923 | +2.1% | 0.34% | -0.9% |
| Q3 2019 | $1,969,000 | -2.3% | 13,634 | -3.4% | 0.34% | -4.7% |
| Q2 2019 | $2,016,000 | +18.9% | 14,109 | +6.0% | 0.36% | +0.6% |
| Q1 2019 | $1,696,000 | +27.9% | 13,311 | +1.4% | 0.36% | +12.5% |
| Q4 2018 | $1,326,000 | -13.6% | 13,131 | -8.8% | 0.32% | -2.1% |
| Q3 2018 | $1,534,000 | +8.5% | 14,392 | -0.8% | 0.33% | +2.5% |
| Q2 2018 | $1,414,000 | -11.8% | 14,505 | -12.4% | 0.32% | -14.0% |
| Q1 2018 | $1,604,000 | -3.5% | 16,551 | -8.1% | 0.37% | -0.3% |
| Q4 2017 | $1,663,000 | +27.2% | 18,018 | +17.7% | 0.37% | -13.5% |
| Q3 2017 | $1,307,000 | +6.0% | 15,303 | +4.4% | 0.43% | -14.5% |
| Q2 2017 | $1,233,000 | -1.4% | 14,661 | -0.2% | 0.50% | +20.3% |
| Q1 2017 | $1,251,000 | +5.9% | 14,692 | -2.5% | 0.42% | -5.2% |
| Q4 2016 | $1,181,000 | +3.1% | 15,067 | +3.6% | 0.44% | -1.8% |
| Q3 2016 | $1,145,000 | -53.2% | 14,542 | -41.9% | 0.45% | -15.3% |
| Q2 2016 | $2,445,000 | +106.7% | 25,009 | +100.5% | 0.53% | +1.3% |
| Q1 2016 | $1,183,000 | +5.8% | 12,476 | +3.7% | 0.52% | -14.4% |
| Q4 2015 | $1,118,000 | +13.3% | 12,035 | +4.0% | 0.61% | +5.7% |
| Q3 2015 | $987,000 | +6480.0% | 11,575 | +6514.3% | 0.58% | +4716.7% |
| Q2 2015 | $15,000 | 0.0% | 175 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $15,000 | – | 175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |